Han, Kelong <br/><br/>
Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation.  [electronic resource] 

 -  British journal of clinical pharmacology  Jan 2016 
 - 148-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Validation Study 
<br/><br/><label>ISSN: </label>1365-2125 
<br/><br/><label>Standard No.: </label>10.1111/bcp.12778  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Angiogenesis Inhibitors--administration & dosage<br/>Bevacizumab--administration & dosage<br/>Body Weight<br/>Child<br/>Child, Preschool<br/>Humans<br/>Infant<br/>Models, Biological<br/>Neoplasms--drug therapy<br/>Practice Guidelines as Topic<br/>Young Adult